NEUARTIGE 4-7-PEPTIDDIMERANTAGONISTEN

European patent · EP2981544 · Deleted

Register entry

Publication number: EP2981544
Application number: EP14779463
Kind: European patent with effect for Switzerland and Liechtenstein
Status: Deleted
Specification: Granted
Filed: Mar 31, 2014
Published: Feb 10, 2016
Granted: Sep 4, 2019
Deleted: Mar 31, 2020
Reason: Annual fee unpaid
IPC classes: C07K 7/08 (2006.01)
A61K 38/10 (2006.01)
A61P 1/00 (2006.01)
Priority: US 201361807714 P 02.04.2013
US 201414229784 28.03.2014
PCT application: PCT/US2014/032391 31.03.2014
PCT publication: WO2014/165448 09.10.2014
Filing language: English
Source: Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

Oct 21, 2020
Deleted, fee unpaid
Published in Swissreg on 21.10.2020
Sep 4, 2019
Granted
Published in Swissreg on 04.09.2019

Parties

Holder

Protagonist Therapeutics, Inc.

Protagonist Therapeutics Inc.

7707 Gateway Boulevard, Suite 140, Newark, CA 94560, US

Inventor

PATEL, Dinesh V.

Fremont, California 94539, US

BHANDARI, Ashok

Pleasanton, California 94588, US

MATTHEAKIS, Larry C.

Cupertino, California 95104, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.